NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT02352558 2023-11-14A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic MalignanciesSumitomo Pharma America, Inc.Phase 1 Completed15 enrolled
NCT00025415 2013-02-07Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionNational Cancer Institute (NCI)Phase 1 Completed60 enrolled